Company Overview
Snapshot
Founded in December 1999 by Meir Haber, Biota operates with 1–10 employees. The company focuses on developing and commercializing bioadhesive technologies, specifically its patented AlgiFilm filmstrips for drug and supplement delivery.
Business overview
Biota is a specialized drug-delivery company that develops and commercializes bioadhesive technologies and products. Its core offering, AlgiFilm filmstrips, provides a versatile and precise oral mucoadhesive system designed to improve patient compliance for pharmaceuticals and nutritional supplements. The technology allows for modulated disintegration times, offering advantages such as taste-masking and enhanced bioavailability. Biota serves the pharmaceutical and biotechnology sectors within the broader healthcare and life sciences industries, with ongoing research into marine algae for novel biomimetic adhesives.
Log in to access full profile ›Company Intelligence Q&A
- What is Biota's primary focus?
- Biota is a drug-delivery company specializing in bioadhesive technologies and products, particularly oral filmstrips for drug and supplement delivery.
- When was Biota founded and by whom?
- Biota was founded in December 1999 by Meir Haber.
- What is AlgiFilm?
- AlgiFilm refers to Biota's patented oral mucoadhesive filmstrips, which are a versatile drug-delivery system designed to improve patient compliance for pharmaceuticals and nutritional supplements.
- What are the key advantages of Biota's AlgiFilm technology?
- AlgiFilm filmstrips offer modulated disintegration times, ranging from under a minute to several hours, providing benefits such as taste-masking and improved bioavailability for administered substances.
- What additional research areas is Biota exploring?
- Biota is also researching marine algae as a potential source for novel biomimetic adhesives, expanding its focus within bioadhesive technologies.